Clinical Trial Update: Gabapentin as a Pre-emptive Analgesic in Oral and Maxillofacial Surgical Procedures [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessing gabapentin as a pre-emptive analgesic in oral and maxillofacial surgery was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Facial Pain
• Pain
• Pain Postoperative

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Pain, Postoperative, Acute Pain | Phase 4 | Status: WITHDRAWN